References
- 1. Reardon AJ, Le Goff M, Briggs MD, McLeod D, Sheehan JK, Thornton DJ, et al. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem. 2000; 275:2123-9.
- 2. Ramesh S, Bonshek RE, Bishop PN. Immunolocalisation of opticin in the human eye. Br J Ophthalmol. 2004; 88:697-702.10.1136/bjo.2003.031989
- 3. Hindson VJ, Gallagher JT, Halfter W, Bishop PN. Opticin binds to heparan and chondroitin sulfate proteoglycans. Invest Ophthalmol Vis sci. 2005; 46: 4417-23.
- 4. Forrester JV. Shedding light on a new eye protein. Br J Ophthalmol. 2004; 88:602-3.10.1136/bjo.2003.034918
- 5. Le Goff MM, Slevin MA, Bishop PN. Opticin is an inhibitor of VEGF-A and FGF-2-activated angiogenesis. Invest Ophthalmol Vis Sci. 2005; 46:S451.
- 6. Le Goff MM, Hindson VJ, Jowitt TA, Scott PG, Bishop PN. Characterization of opticin and evidence of stable dimerization in solution. J Biol Chem. 2003; 278: 45280-7.
- 7. Friedman JS, Faucher M, Hiscott P, Biron VL, Malenfant M, Turcotte P, et al. Protein localization in the human eye and genetic screen of opticin. Hum Mol Genet. 2002; 11:1333-42.10.1093/hmg/11.11.1333
- 8. Le Goff MM, Slevin MA, Bishop PN. Opticin is an inhibitor of VEGF-A and FGF-2-activated angiogenesis. Annual Invest Ophthalmol Vis Sci. 2005; 46:451.
- 9. Sanders EJ, Walter MA, Parker E, Arámburo C, Harvey S. Opticin binds retinal growth hormone in the embryonoic vitreous. Invest Ophthalmol Vis Sci. 2003; 44:5404-9.
- 10. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 283-90.10.1016/S0278-5846(03)00023-X
- 11. Hobby P, Wyatt MK, Gan W, Bernstein S, Tomarev S, Slingsby C, et al. Cloning , modeling , and chromosomal localization for a small leucine-rich repeat proteoglycan (SLRP) family member expressed in human eye. Mol Vis. 2000; 6:72-8.
- 12. Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, et al. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem. 2005; 280:27935-48.
- 13. Matthew JS, Magali LG, David W, Paul B, Mark S. Antiangiogenic properties of opticin. The FASEB Journal. 2007; 21:601.
- 14. Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 2005; 65:3967-79.10.1158/0008-5472.CAN-04-2427
- 15. Sneddon SF, Telfer BA, Williams KJ, Bishop PN, Stratford IJ, Cowen RL. Opticin:a potent antiangiogenic/antiproliferative agent for breast cancer therapy. Breast Cancer Research. 2010; 12:53-63.10.1186/bcr2550
- 16. Pattwell DM, Sheridan CM, Le Goff M, Bishop PN, Hiscott P. Localisation of opticin in human proliferative retinal disease. Exp Eye Res. 2010; 90:461-4. 10.1016/j.exer.2009.12.007